Tower Research Capital LLC (Trc) Ocugen, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ocugen, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,728 shares of OCGN stock, worth $7,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,728
Previous 16,589
41.36%
Holding current value
$7,490
Previous $25,000
64.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding OCGN
# of Institutions
124Shares Held
78.3MCall Options Held
535KPut Options Held
523K-
Black Rock Inc. New York, NY17.9MShares$13.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.9MShares$13.1 Million0.0% of portfolio
-
State Street Corp Boston, MA15.8MShares$12.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$4.83 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.89 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $167M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...